前列腺癌评估多参数MRI中的偶然发现
回顾580例患者共684份前列腺多参数MRI报告,发现233例(40%)存在349个真性偶然发现,其中仅6.6%为有临床意义的非泌尿系统发现;另有119个额外前列腺外发现与前列腺癌分期直接相关。作者认为前列腺适应证MRI的偶然发现率与其他腹盆腔影像检查相似,需进一步研究这些偶然发现的下游检查和费用。
要点
- 前列腺多参数MRI中40%(233/580)患者存在真性偶然发现,但仅6.6%为有临床意义的非泌尿系统发现。
- 超过三分之一的MRI报告含有与前列腺癌无关的泌尿系统偶然发现。
- 另有119个额外前列腺外发现虽非预期,但与前列腺癌分期直接相关,不应归为真性偶然发现。
核心结论
- 前列腺适应证多参数MRI的偶然发现率与其他腹盆腔影像检查相似,但仅6.6%的偶然发现为有临床意义的非泌尿系统发现;需进一步研究这些偶然发现的下游检查和由此产生的费用。
研究设计与样本
- 回顾性分析连续684份前列腺多参数MRI报告,来自580例患者;方案包括三平面T2加权、扩散加权和动态对比增强盆腔MRI,以及增强后腹盆腔MRI,主要适应证为前列腺癌检出或评估。
关键影像表现/征象
- 349个真性偶然发现分布于233例(40%)患者,其中多数为非泌尿系统发现。
- 仅6.6%的真性偶然发现为有临床意义的非泌尿系统发现。
- 超过三分之一的MRI报告含有与前列腺癌无关的泌尿系统偶然发现。
- 另有119个额外前列腺外发现虽非预期,但与前列腺癌分期直接相关,不属于真性偶然发现。
临床应用与阅片要点
- 阅片时需区分与前列腺癌分期直接相关的前列腺外发现和真性偶然发现,后者与检查适应证无关。
- 真性偶然发现中仅6.6%为有临床意义的非泌尿系统发现,多数为非泌尿系统发现。
- 超过三分之一的报告含与前列腺癌无关的泌尿系统偶然发现。
- 作者认为需进一步研究这些偶然发现的下游检查和由此产生的费用。
局限性
- 需进一步研究以评估这些偶然发现的下游检查和由此产生的费用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Multiparametric magnetic resonance imaging (mp-MRI) and MRI/Ultrasound (US) fusion-guided biopsy are relatively new techniques for improved detection, staging, and active surveillance of prostate cancer (PCa). As with all imaging modalities, MRI reveals incidental findings (IFs) which carry the risk of increased cost, patient anxiety, and iatrogenic morbidity due to workup of IFs. Herein, we report the IFs from 684 MRIs for evaluation of PCa and consider their characteristics and clinical significance.
METHODS: Patients underwent mp-MRI prostate protocol incorporating triplanar T2-weighted, diffusion-weighted, and dynamic contrast-enhanced pelvic MRI as well as a post-contrast abdominopelvic MRI with the primary indication of detection or evaluation of PCa. A total of 684 consecutive prostate MRI reports performed in a series of 580 patients were reviewed. All extraprostatic findings reported were logged and then categorized by organ system and potential clinical significance.
RESULTS: There were 349 true IFs found in 233 (40%) of the 580 patients. One hundred nineteen additional extraprostatic findings were unsuspected but directly related to PCa staging, while the 349 IFs were unrelated and thus truly incidental beyond study indication. While the majority of true IFs were non-urologic, only 6.6% of IFs were considered clinically significant, non-urologic findings, and more than a third of MRI reports had urologic IFs not related to PCa.
CONCLUSIONS: Rates of incidental findings on prostate indication MRI are similar to other abdominopelvic imaging studies. However, only 6.6% of the IFs were considered to be clinically significant non-urologic findings. Further investigations are needed to assess downstream workup of these IFs and resulting costs.
引用
- Sherrer RL, Lai WS, Thomas JV, et al. Incidental findings on multiparametric MRI performed for evaluation of prostate cancer. Abdom Radiol (NY). 2018. PMID: 28677001. doi:10.1007/s00261-017-1237-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。